Skip to main content

Role of cardiovascular magnetic resonance in the prognosis of patients with myocardial infarction with non-obstructive coronary arteries



It is estimated that 5% to 10% of patients with myocardial infarction (MI) present with no obstructive coronary artery lesions. Until now, most studies have focused on acute coronary syndrome, including different clinical entities with a similar presentation encompassed under the term MINOCA (MI with non-obstructive coronary arteries). The aim of this study is to assess the prognosis of patients diagnosed with true infarction, confirmed by cardiovascular magnetic resonance (CMR), in the absence of significant coronary lesions.


Prospective multicenter registry study, including 120 consecutive patients with a CMR-confirmed MI without obstructive coronary artery lesions. The primary clinical outcome was major adverse cardiovascular events (MACE: death, non-fatal infarction, stroke, or cardiac readmission), assessed over three years.


Seventy-six patients (63.3%) were admitted with a diagnosis of acute coronary syndrome, and 44 (36.6%) for other causes (mainly heart failure); the definitive diagnosis was established by CMR. Most patients (64.2%) were men, and the mean age was 58.8 ± 13.5 years. Patients presented with small infarcts: 83 (69.1%) showed late gadolinium enhancement (LGE) in one or two myocardial segments, mainly transmural (in 77.5% of patients) and with a preserved left ventricular ejection fraction (median 54.8%, interquartile range 37–62). The most frequent infarct location was inferolateral (n = 38, 31.7%). During follow-up, 43 patients (35.8%) experienced a MACE, including 9 (7.5%) who died. In multivariable analysis, LGE in two versus one myocardial segment doubled the risk of adverse cardiac events (hazard ratio [HR] 2.32, 95% confidence interval [CI] 0.97–5.83, p = 0.058). Involvement of three or more myocardial segments almost tripled the risk (HR 2.71, 95% CI 1.04–7.04, p = 0.040 respectively).


Patients with true MI but without significant coronary artery lesions predominantly had small infarcts. Myocardial 3-segment LGE involvement is associated with a significantly higher risk of adverse cardiac events.


The main physiopathological mechanism underlying acute coronary syndrome (ACS) is local and systemic inflammation, which provokes the rupture of an atheromatous plaque and subsequent coronary thrombosis [1]. Although ACS is generally associated with obstructive coronary artery disease, in up to 30% of these patients neither plaque nor thrombosis are visible in the coronary angiography [2]. This situation has occurred more frequently in recent years, in large part due to increased access to coronary angiography and the existence of more sensitive and specific troponins for diagnosing myocardial infarction (MI) [3]. These advances have led to the definition of a new entity, MI with non-obstructive coronary arteries (MINOCA), whose diagnosis is established when the coronarography shows the following features: (a) it meets universal criteria for MI; (b) the coronary angiogram shows no obstruction of the coronary arteries, defined as the absence of coronary diameter stenosis > 50% on any artery that is potentially responsible for the MI; and (c) there is no specific or overt clinical cause for acute presentation [4]. There are also non-ischemic or non-thrombotic clinical entities that can present with a similar clinical profile to myocardial infarction, such as myocarditis or Takotsubo syndrome. As their prognostic and therapeutic management are different, it is vital to reach an accurate diagnosis in these patients [5].

Cardiovascular magnetic resonance (CMR), especially when employing late gadolinium enhancement (LGE) techniques, is a highly sensitive, non-invasive imaging modality for detecting alterations of the myocardium, allowing identification of the etiology in 65% to 90% of cases with MINOCA [5,6,7]. Gadolinium is a low molecular weight compound that easily penetrates the capillary pores and spreads throughout the extracellular space. In a normal myocardium, it is washed out in a short period of time, whereas it builds up in the case of myocardial necrosis. The LGE study applies an inversion time, which nulls the signal from the normal myocardium (it appears hypoenhanced). This reveals the hyperenhanced myocardial necrosis with very high sensitivity. CMR is the only imaging technique capable of detecting small foci of fibrosis.

Several investigators have used CMR to analyze diverse cohorts of patients with ACS but without coronary obstruction in the angiographic study [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19]. The results are not neatly concordant; most cases are considered myocarditis, while only a fraction are true infarctions. Therefore, the prognosis of patients diagnosed with MINOCA and having true MIs (free of the influence of non-ischemic entities) is not well defined. Moreover, the role of CMR for evaluating the prognosis of these patients is also unknown.

The primary aim of this study is to assess the medium-term prognosis of patients with CMR-confirmed MI but without significant lesions on coronary angiography. Moreover, we investigate the morphological characterization of this type of MI on CMR and its relationship with adverse cardiac events during follow-up.


This was a multicenter descriptive, prospective study, with a small proportion of retrospectively included patients. We included consecutive patients from our CMR unit, referred from eight centers from May 2009 to June 2017, either during admission for an acute cardiologic event (ACS, heart failure, or ventricular tachycardia) or soon after discharge, when an invasive coronary angiography showed no significant coronary artery lesions. Patients were followed for a median of 2.9 years.

Exclusion criteria were: history of ischemic cardiomyopathy, regardless of revascularization; coronary diameter stenosis of > 50% on the conventional angiography; or midwall/subepicardial LGE with preserved endomyocardium (suggestive of myocarditis or other cardiomyopathies) or its absence on the LGE images.

During the study period, 27,752 coronarographies were performed in patients who had an initial diagnosis of ACS, chest pain, heart failure, or ventricular arrhythmia. CMRs were performed in 2198 of these patients, as indicated by the attending physician. The final study cohort consisted of 120 patients with subendocardial or transmural LGE, compatible with a defined coronary territory and absence of coronary artery diameter stenosis > 50% on angiography. Coronary artery angiograms were performed in three different centers. Studies were additionally reviewed in each one of those centers by another expert interventional cardiologist different from the one who had performed and reported the study. The patient flow chart is shown in Fig. 1.

Fig. 1

Patient inclusion flowchart. *ACS acute coronary syndrome; CP chest pain; HF acute heart failure; CMR cardiovascular magnetic resonance; MI myocardial infarction; LGE, late gadolinium enhancement

Clinical and epidemiological variables as well as data related to the coronary angiography and post-discharge treatment were collected. The attending physicians decided on the drug treatment and disease management strategy. Investigators completed follow-up phone interviews and reviews of patients’ clinical records in 99.2% of the cases.

The estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease (MDRD) Study equation. All coronary angiograms were reviewed by a second expert interventional cardiologist. The study protocol complied with the Declaration of Helsinki and was approved by the research ethics committee of the reference hospital. All patients provided written informed consent.


The primary endpoint was the appearance of major adverse cardiovascular events (MACE) at follow-up, defined as death from any cause, non-fatal infarction, stroke, or cardiac readmission.

CMR protocol

CMR studies were performed using a 1.5 T CMR scanner (Intera, Philips Healthcare, Best, the Netherlands) and a multichannel phased-array antenna devoted to cardiac studies. All images were acquired during breath-holds and were electrocardiogram (ECG)-triggered. The following sequences were performed:

  1. 1.

    Cine Imaging (balanced steady-state free precession [bSSFP]) with at least 20 phases per cardiac cycle (8 mm slice thickness plus 2 mm gap; repetition time/echo time 3.3/1.65 ms; flip angle 60°; matrix 256 × 220). The following planes were obtained: two chamber, four chamber, three chamber and short axis with full left ventricle (LV) coverage from the mitral valve plane to the apex.

  2. 2.

    T2-STIR (short time inversion recovery) black blood sequence turbo spin echo [TSE] on short axis plane (slice thickness: 8 mm plus 2 mm gap, repetition time 2 × R to R interval (RR), echo time 100 ms, matrix 256 × 256).

  3. 3.

    LGE: T1-enhanced, 3-dimensional inversion recovery turbo gradient echo sequence (T1-turbo field echo, repetition time/echo time 4.0/1.24 ms; flip angle 15°; REC voxel MPS 1.5 × 1.5 mm), 10 min after administration of 0.1 mmol/kg of gadobutrol (Gadovist, Bayer Healthcare, Berlin, Germany) on two-chamber, four-chamber, and short axis planes (again covering the entire myocardium). The inversion time was adjusted individually to null the healthy myocardium, oscillating from 250 to 300 ms.

CMR analysis

One expert CMR radiologist performed the image analysis on an independent workstation provided by the manufacturer (View-Forum release 6.3, Philips Healthcare). In cine imaging, LV ejection fraction (LVEF) (%), end-diastolic volume (LVEDV) and end-systolic (ml/m2) volume (LVESV), as well as LV mass (g/m2) were calculated by semiautomatic planimetry of the endocardial and epicardial borders on all short-axis views. Also, right ventricle (RV) ejection fraction (RVEF) (%), end-diastolic volume (RVEDV), and end-systolic (ml/m2) volume (RVESV) were obtained, again by planimetry of the endocardial border on all short-axis views. A 17-segment model of the heart was used to visually determine the presence of either myocardial edema on T2-STIR weighted-images, or contrast enhancement on LGE images. When myocardial edema and LGE coincided, the finding was considered to be related to the acute onset. The inter and intra-observer variability for the quantification of all exposed CMR parameters in our unit has previously been determined as less than 5%.

Statistical analysis

Data were entered onto an Excel spreadsheet (Microsoft Corporation, Redmond, Washington, USA) and exported to Stata (version 13.1, StataCorp; College Station, Texas, USA). Categorical variables were expressed as absolute and relative frequencies, while continuous variables were assessed for normality using the Shapiro–Wilk test and expressed as mean and standard deviation (SD) or median and interquartile range (IQR), as appropriate.

Mortality and MACE observed during follow-up were expressed as percentages. Initially, a univariable analysis was performed to test the association between cardiovascular disease risk factors and comorbidity, analytical data and post-discharge treatment. Then a multivariable Cox regression was used to assess the relationship between predictor variables and cardiovascular events; the final model included all variables yielding a p value under 0.05 in univariable analysis, along with any other clinical variables that could plausibly influence the outcome, such as age, sex and different medical treatments upon discharge.


Patients had a mean age of 58.8 years, and 64.2% were men. Half (51.7%) were hypertensive, while just 16.7% were diabetic. The main reason for ordering a coronary angiography was ACS (n = 76, 63.3%), followed by heart failure (n = 37, 30.8%) and ventricular arrhythmias (n = 7, 5.8%). Table 1 shows patients’ demographic and baseline clinical characteristics.

Table 1 Baseline subject characteristics (N = 120)

A high proportion of patients presented arrhythmias at high thrombotic risk; 17 patients (14.2%) had a history of atrial fibrillation (AF). Another 12 patients (10%) were diagnosed with AF during their hospital stay, and 8 (6.7%) developed this condition during follow-up. All told, 11 patients (9.2%) presented an intraventricular thrombus.

On the angiography, 63.3% of the patients had angiographically normal coronary arteries, while 21.7% were described as having parietal irregularities or coronary artery ectasia, and 15% had non-significant (< 50% obstruction) atherosclerotic lesions. Thirty-three patients (27.5%) underwent a ventriculography, and 65% presented segmental contractility abnormalities (Table 2).

Table 2 Diagnostic imaging results

The CMR was performed at a median of 12 days. LGE demonstrated transmural enhancement in 93 cases (77.5%), and subendocardial enhancement in 19 (15.8%). Eight patients, (6.7%) had both types in two distinct regions (Fig. 2). Almost three-quarters of the patients (69.8%) presented with a small infarction on LGE, defined as enhancement in one or two LV segments. The most frequent infarct location was the inferolateral wall (Table 2; Fig. 2).

Fig. 2

CMR images. a Focal transmural inferoseptal acute myocardial infarction. Left: T2 short tau inversion recovery (STIR) short-axis image showing focal transmural edema. Right: Late gadolinium enhancement (LGE) CMR short-axis corresponding image showing transmural hyperenhancement. b Anterolateral subendocardial acute myocardial infarction. Left: T2 STIR short-axis image showing focal subendocardial edema. LGE short-axis corresponding image showing focal subendocardial hyperenhancement. c Presence of three distinct focal myocardial infarctions: lateroapical, septomedial and inferomedial (red arrows), with images suggestive of thrombus in both ventricles (yellow arrows). LGE images (upper: 2 short-axis views; lower: 4-chamber and 2 chamber views) showing the 3 foci of enhancement. LGE late gadolinium enhancement

In the analysis of treatment upon discharge, we observed an underuse of all drugs recommended to treat ischemic cardiomyopathy; only 67.5% of patients were discharged with a prescription for angiotensin converting-enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARBs); 56.7%, beta-blockers; 59.2%, statins; and 60%, acetylsalicylic acid. Only a fifth of the patients received dual anti-platelet therapy on discharge (Table 1).


Complete follow-up was achieved in 99.2% of the patients, for a median period of 2.9 (IQR 1.5–4.8) years. Nine patients (7.5%) died—2 from cardiovascular causes—and 7 (5.8%) presented a new non-fatal myocardial infarction. More than one third (35.8%) had a MACE (Table 3).

Table 3 Adverse events during follow-up in patients with true myocardial infarctions and coronaries without obstructive lesions

In the univariable analysis, low LVEF, LV dilatation, and MI size were associated with a poor prognosis. The involvement of two myocardial segments in CMR was associated with a twofold increased risk of MACE (hazard ratio [HR] 2.26, 95% confidence interval [CI] 0.98–5.19; p = 0.056) without reaching statistical significance; while involvement of three segments or more almost tripled that risk (HR 2.97, 95% CI 1.26–6.95, p = 0.012). The results in univariable analysis remained significant in multivariable analysis (Table 4; Fig. 3).

Table 4 Independent predictors of adverse cardiovascular events during follow-up, Cox regression analysis
Fig. 3

Kaplan–Meier survival curve for MACE depending on the number of segments affected in the CMR. MACE: non-fatal myocardial infarction, ischemic stroke, death from any cause or readmissions due to cardiac causes


This is the first registry study to assess the role of CMR for evaluating the prognosis of patients with true, CMR-confirmed MI and without significant lesions in the coronary arteries. Thus, we excluded other non-ischemic entities like myocarditis or Takotsubo syndrome. The results suggest that this entity is associated with a high incidence of MACE, including mortality.

To date, published studies have analyzed the clinical characteristics, treatment, and prognosis in patients with MI but without significant coronary lesions, focusing on a heterogeneous group of entities encompassed under MINOCA, including true MI, myocarditis, Takotsubo syndrome, and pulmonary thromboembolism [20]. These entities probably have differential prognoses and characteristics, so outcomes in this clinically diverse population cannot be extrapolated to patients with true MI but without significant lesions. Moreover, infarction in the absence of coronary artery lesions does not always occur in the context of an ACS; it can also present in other clinical scenarios like heart failure or ventricular arrhythmia. Thus, our series includes different forms of presentation in patients with CMR-confirmed MI and coronary artery lesions with obstruction under 50%.

In most published series on MINOCA, patients with an ACS but without significant lesions have been younger and more likely to be women than patients with obstructive lesions [21, 22]. Our sample confirms this tendency, with a younger mean age, a greater proportion of women, and a lower prevalence of risk factors (particularly diabetes) compared to ACS registries in the same population [23,24,25].

There are various mechanisms that can explain the existence of an infarct without the presence of coronary artery lesions, such as coronary spasm, a repermeabilized thrombus, misinterpretation of angiograms or microvascular dysfunction [26,27,28], or coronary artery embolization [29, 30]. This last cause could explain a large portion of the MIs in our cohort given the high prevalence of thrombotic arrhythmias (30.8%). Moreover, neurologists pointed to a probable embolic origin for all the strokes occurring during follow-up.

There was a notably low prescription rate for class I drugs indicated in clinical practice guidelines for secondary prevention of events in ischemic cardiomyopathy (aspirin, dual anti-platelet therapy, beta-blockers, ACEI/ARBs, and statins). This is probably attributable to the lower risk profile in these patients and to delays in diagnostic confirmation by CMR. Just 17.5% of the CMR studies were undertaken during the patients’ index hospitalization, which resulted in 74 (61.7%) patients being discharged with a diagnosis other than MI—modified only in follow-up. This brings to mind the most recent European guidelines for ACS with ST-segment elevation, which recommend performing CMR within two weeks of symptoms onset to optimize diagnostic accuracy and enable the best treatment decisions after the event [4]. Likewise, the new European Society of Cardiology guide for ACS without persistent ST-segment elevation includes a recommendation, with level 1b evidence, to perform CMR in all MINOCA patients [31]. Furthermore, a Swedish study [32] assessed drug treatments in major cardiovascular events (infarction, stroke, all-cause mortality, and admission due to heart failure), reporting beneficial effects for statins and ACEI/ARBs, a positive tendency for beta-blockers, and no effect for dual anti-platelet therapy. However, the study population consisted of all patients discharged from hospital with a diagnosis of acute MI and coronary artery stenosis of < 50%. There was no diagnostic confirmation of true infarctions, so other clinical entities with a similar presentation to ACS could have been included, including conditions with very different prognoses and therapeutic management. The underuse of medical treatment in this entity could contribute to the poor medium-term prognosis.

CMR is the most sensitive and specific technique for diagnosing abnormalities in MINOCA. In our series, patients presented with small infarcts: 83 (69.1%) showed LGE in one or two myocardial segments, mainly transmural (in 77.5% of patients) and with a conserved LVEF (median 54.8%, IQR 37–62). The most frequent location of the infarct was inferolateral (n = 38, 31.7%), with segment 14 (apical septal) remaining the least affected. Furthermore, CMR enables specification of the size and location of the MI, among other parameters that are closely related to the prognosis of patients with ischemic cardiomyopathy. In our study, multivariate analysis showed that the involvement of three or more myocardial segments estimated by CMR was associated with a threefold increase risk in adverse cardiac events in comparison with one-segment involvement (HR 2.97, 95% CI 1.26–6.95, p = 0.012). These findings show that CMR is not only a good diagnostic tool; it could also determine the prognosis in patients with true MI but without significant coronary artery stenoses.

Until recently, scientific evidence on the prognosis of patients with ACS but without significant coronary artery stenoses was based only on a few small studies that indicated an excellent prognosis and high 10-year survival rates [33,34,35]. Emerging evidence shows a worse prognosis, with in-hospital mortality of 0.9% to 4.7% per year [36]. However, all these studies have taken place in the context of ACS, mixing clinical entities whose prognoses are not comparable, which could explain the great variability in the results. Our study, with a median follow-up of 2.9 years, describes a specific population of patients with true infarcts but without significant coronary artery lesions, indicating a poor prognosis. Although two-thirds of the participants had small MIs, the associated mortality was 7.5% and MACE rate was 35.8%. These data are more concordant with the general prognosis of patients with ischemic cardiomyopathy.


Our study has several limitations. One of the limitations of this study is the missing data in baseline characteristics, which is typical of any registry like ours. Moreover, its observational nature makes it impossible to establish a causal relationship, although it does establish associations that can be tested in future studies. The fact that the study was observational also means that it did not influence how clinicians managed patients’ diagnosis and treatment, so CMR may have been underutilized in patients with acute events but no significant lesions. Another limitation is that no intracoronary imaging techniques were used; these may have identified acute ruptures in plaque that were not apparent on the conventional coronarography.

An additional limitation of the study is the existence of pathologies with findings that could be similar in CMR, such as sarcoid or hypereosinophilic syndromes. However, the clinical context, together with analytical data and other complementary tests, led us to the final diagnosis of MINOCA.

The study was in patients with CMR-confirmed MI but without significant coronary artery lesions, including patients with MINOCA but also other forms of presentation, such as ventricular arrhythmias or acute heart failure. We consider this to be the greatest strength of our study, as we included a population (CMR-diagnosed infarction) that has not been specifically studied up to now and whose prognosis was heretofore unknown.


Patients with CMR-confirmed true MI and without significant coronary artery stenoses have a poor medium-term prognosis, with a high incidence of cardiovascular events and mortality. This type of MI is predominantly small. Involvement of three or more myocardial segments is associated with a significantly higher risk of adverse cardiac events. Our study reflects the importance of performing CMR in patients with MINOCA in order to improve the diagnosis of infarction and apply adequate secondary prevention measures.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.



Angiotensin converting enzyme inhibitor


Acute coronary syndrome


Atrial fibrillation


Angiotensin receptor blocker


Balanced steady state free precession


Cardiovascular magnetic resonance




Estimated glomerular filtration rate


Late gadolinium enhancement


Left venricle/left ventricular


Left ventricular end-diastolic volume


Left ventricular end-diastolic volume index


Left ventricular ejection nfraction


Left ventricular end-systolic volume


Left ventricular end-systolic volume index


Major adverse cardiovascular events


Myocardial infarction


Myocardial infarction with no obstructive coronary arteries


Right ventricle/right ventricular


Right ventricular end-diastolic volume


Right ventricular end-diastolic volume index


Right ventricular ejection fraction


Right ventricular end-systolic volume


Right ventricular end-systolic volume index


Short tau inversion recovery


Short tau inversion recovery


Turbo spin echo


  1. 1.

    Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365–72.

    CAS  Article  Google Scholar 

  2. 2.

    Johnston N, Jönelid B, Christersson C, Kero T, Renlund H, Schenck-Gustafsson K, et al. Effect of gender on patients with ST-elevation and non-ST-elevation myocardial infarction without obstructive coronary artery disease. Am J Cardiol. 2015;115:1661–6.

    Article  Google Scholar 

  3. 3.

    Agewall S, Eurenius L, Hofman-Bang C, Malmqvist K, Frick M, Jernberg T, et al. Myocardial infarction with angiographically normal coronary arteries. Atherosclerosis. 2011;219:10–4.

    CAS  Article  Google Scholar 

  4. 4.

    Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–77.

    Article  Google Scholar 

  5. 5.

    Leurent G, Langella B, Fougerou C, Lentz P-A, Larralde A, Bedossa M, et al. Diagnostic contributions of cardiac magnetic resonance imaging in patients presenting with elevated troponin, acute chest pain syndrome and unobstructed coronary arteries. Arch Cardiovasc Dis. 2011;104:161–70.

    Article  Google Scholar 

  6. 6.

    Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J. 2007;28:1242–9.

    CAS  Article  Google Scholar 

  7. 7.

    Laraudogoitia E, Pérez-David E, Larena JA, Velasco del Castillo S, RumorosoCuevas JR, Onaindía JJ, et al. The value of cardiac magnetic resonance in patients with acute coronary syndrome and normal coronary arteries. Rev Esp Cardiol. 2009;62:976–83.

    Article  Google Scholar 

  8. 8.

    Collste O, Sörensson P, Frick M, Agewall S, Daniel M, Henareh L, et al. Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study. J Intern Med. 2013;273:189–96.

    CAS  Article  Google Scholar 

  9. 9.

    Stensaeth KH, Fossum E, Hoffmann P, Mangschau A, Klow NE. Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. Int J Cardiovasc Imaging. 2011;27:355–65.

    CAS  Article  Google Scholar 

  10. 10.

    Mahmoudi M, Harden S, Abid N, Peebles C, Nicholas Z, Jones T, et al. Troponin-positive chest pain with unobstructed coronary arteries: definitive differential diagnosis using cardiac MRI. Br J Radiol. 2012;85:e461-466.

    CAS  Article  Google Scholar 

  11. 11.

    Kawecki D, Morawiec B, Monney P, Pellaton C, Wojciechowska C, Jojko J, et al. Diagnostic contribution of cardiac magnetic resonance in patients with acute coronary syndrome and culprit-free angiograms. Med Sci Monit. 2015;21:171–80.

    CAS  Article  Google Scholar 

  12. 12.

    Christiansen JP, Edwards C, Sinclair T, Armstrong G, Scott A, Patel H, et al. Detection of myocardial scar by contrast-enhanced cardiac magnetic resonance imaging in patients with troponin-positive chest pain and minimal angiographic coronary artery disease. Am J Cardiol. 2006;97:768–71.

    Article  Google Scholar 

  13. 13.

    Hermens JAJM, van Es J, von Birgelen C, Opden Akker JW, Wagenaar LJ. Evidence of myocardial scarring and microvascular obstruction on cardiac magnetic resonance imaging in a series of patients presenting with myocardial infarction without obstructed coronary arteries. Int J Cardiovasc Imaging. 2014;30:1097–103.

    Article  Google Scholar 

  14. 14.

    Gerbaud E, Harcaut E, Coste P, Erickson M, Lederlin M, Labèque JN, et al. Cardiac magnetic resonance imaging for the diagnosis of patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Int J Cardiovasc Imaging. 2012;28:783–94.

    Article  Google Scholar 

  15. 15.

    Dastidar AG, Rodrigues JCL, Ahmed N, Baritussio A, Bucciarelli-Ducci C. The role of cardiac MRI in patients with troponin-positive chest pain and unobstructed coronary arteries. Curr Cardiovasc Imaging Rep. 2015;8:28.

    Article  Google Scholar 

  16. 16.

    Steen H, Madadi-Schroeder M, Lehrke S, Lossnitzer D, Giannitsis E, Katus HA. Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson. 2010;12:51.

    Article  Google Scholar 

  17. 17.

    Chu G, Zhang G, Zhu M, Zhang Z, Wu Y, Zhang H. Acute one-stop cardiovascular magnetic resonance imaging for differential diagnosis in patients with acute coronary syndrome and unobstructed coronary arteries. Med Princ Pract Int J Kuwait Univ Health Sci Cent. 2015;24:325–31.

    Google Scholar 

  18. 18.

    Saba L, Fellini F, De Filippo M. Diagnostic value of contrast-enhanced cardiac magnetic resonance in patients with acute coronary syndrome with normal coronary arteries. Jpn J Radiol. 2015;33:410–7.

    Article  Google Scholar 

  19. 19.

    Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Diagnostic value of CMR in patients with biomarker-positive acute chest pain and unobstructed coronary arteries. JACC Cardiovasc Imaging. 2010;3:661–4.

    Article  Google Scholar 

  20. 20.

    Dastidar AG, Baritussio A, De Garate E, Drobni Z, Biglino G, Singhal P, et al. Prognostic role of cardiac MRI and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc Imaging. 2019;12:1973–82.

    Article  Google Scholar 

  21. 21.

    Germing A, Lindstaedt M, Ulrich S, Grewe P, Bojara W, Lawo T, et al. Normal angiogram in acute coronary syndrome-preangiographic risk stratification, angiographic findings and follow-up. Int J Cardiol. 2005;99:19–23.

    CAS  Article  Google Scholar 

  22. 22.

    Da Costa A, Isaaz K, Faure E, Mourot S, Cerisier A, Lamaud M. Clinical characteristics, aetiological factors and long-term prognosis of myocardial infarction with an absolutely normal coronary angiogram; a 3-year follow-up study of 91 patients. Eur Heart J. 2001;22:1459–65.

    Article  Google Scholar 

  23. 23.

    Orenes-Piñero E, Ruiz-Nodar JM, Esteve-Pastor MA, et al. Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome. Oncotarget. 2017;8:80182–91.

    Article  Google Scholar 

  24. 24.

    Rivera-Caravaca JM, Ruiz-Nodar JM, Tello-Montoliu A, Esteve-Pastor MA, Veliz-Martínez A, Orenes-Piñero E, et al. Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry. Eur J Cardiovasc Nurs J Work Group Cardiovasc Nurs Eur Soc Cardiol. 2017;16:696–703.

    Google Scholar 

  25. 25.

    Vicente-Ibarra N, Marín F, Pernías-Escrig V, Sandín-Rollán M, Núñez-Martínez L, Lozano T, et al. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. Eur J Intern Med. 2019;61:48–53.

    Article  Google Scholar 

  26. 26.

    Sztajzel J, Mach F, Righetti A. Role of the vascular endothelium in patients with angina pectoris or acute myocardial infarction with normal coronary arteries. Postgrad Med J. 2000;76:16–21.

    CAS  Article  Google Scholar 

  27. 27.

    Bulkley BH, Klacsmann PG, Hutchins GM. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am Heart J. 1978;95:563–9.

    CAS  Article  Google Scholar 

  28. 28.

    Sun H, Mohri M, Shimokawa H, Usui M, Urakami L, Takeshita A. Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina. J Am Coll Cardiol. 2002;39:847–51.

    Article  Google Scholar 

  29. 29.

    Erbel R, Heusch G. Coronary microembolization. J Am Coll Cardiol. 2000;36:22–4.

    CAS  Article  Google Scholar 

  30. 30.

    Alpert JS. Fascination with myocardial infarction and normal coronary arteries. Eur Heart J. 2001;22:1364–6.

    CAS  Article  Google Scholar 

  31. 31.

    Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–367.

    Article  Google Scholar 

  32. 32.

    Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskjöld A, Gard A, et al. Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Circulation. 2017;135:1481–9.

    Article  Google Scholar 

  33. 33.

    Larsen AI, Nilsen DWT, Yu J, Mehran R, Nikolsky E, Lansky AJ, et al. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). Am J Cardiol. 2013;111:643–8.

    Article  Google Scholar 

  34. 34.

    Ammann P, Marschall S, Kraus M, Schmid L, Angehrn W, Krapf R, et al. Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries. Chest. 2000;117:333–8.

    CAS  Article  Google Scholar 

  35. 35.

    Chopard R, Jehl J, Dutheil J, Genon VD, Seronde M-F, Kastler B, et al. Evolution of acute coronary syndrome with normal coronary arteries and normal cardiac magnetic resonance imaging. Arch Cardiovasc Dis. 2011;104:509–17.

    Article  Google Scholar 

  36. 36.

    Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131:861–70.

    CAS  Article  Google Scholar 

Download references


Not applicable.


The manuscript has not received any funding.

Author information




VN, FE, RJ Conception and design of project. FE, CVP, CSP, RJ Data acquisition. Interventional cardiologist who reviewed the coronary angiography of each patient. FE CMR sequence design and optimization. VN, FE, RJ Collaboration in data interpretation and analysis. VN, FE, BV, MP, RJ Manuscript draft and revision. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Juan Miguel Ruiz-Nodar.

Ethics declarations

Ethics approval and consent to participate

The study protocol complied with the Declaration of Helsinki and was approved by the research ethics committee of the reference hospital (Elche University Hospital).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vicente-Ibarra, N., Feliu, E., Bertomeu-Martínez, V. et al. Role of cardiovascular magnetic resonance in the prognosis of patients with myocardial infarction with non-obstructive coronary arteries. J Cardiovasc Magn Reson 23, 83 (2021).

Download citation


  • Myocardial infarction with no obstructive coronary arteries
  • Cardiovascular magnetic resonance
  • Adverse cardiovascular events
  • Myocardial infarction